Marubi(SH:603983)2021-04-23 16:00Dividend Distribution - The company plans to distribute a cash dividend of 3.50 RMB per 10 shares (including tax) to all shareholders registered on the dividend distribution date[6]. - In 2019, the company distributed a cash dividend of 3.90 RMB per 10 shares, totaling 156,390,000 RMB, which accounted for 30.37% of the net profit attributable to shareholders[122]. - For 2020, the cash dividend was set at 3.50 RMB per 10 shares, amounting to 140,636,860 RMB, representing 30.28% of the net profit attributable to shareholders[123]. - The company has a stable cash dividend policy, ensuring that cash dividends will account for at least 10% of the distributable profits each year[118]. - The board of directors is responsible for formulating the annual profit distribution plan, which is then reviewed by the supervisory board and submitted to the shareholders' meeting for approval[119]. - The cash dividends distributed in 2019 and 2020 were part of a consistent policy aimed at returning value to shareholders[122]. - The company’s dividend distribution strategy reflects its commitment to maintaining a stable return on equity for its shareholders[122]. - The company has not proposed any cash profit distribution plan for the reporting period despite having positive distributable profits[123]. Financial Performance - The company reported a significant increase in revenue for 2020 compared to 2019, with specific figures to be detailed in the financial data section[21]. - The company's operating revenue for the reporting period was approximately CNY 1.74 billion, a decrease of 3.10% compared to the previous year[23]. - Net profit attributable to shareholders was approximately CNY 464.40 million, down 9.81% year-over-year[23]. - The net cash flow from operating activities decreased by 22.17% to approximately CNY 362.35 million[23]. - The company's total assets increased by 10.44% to approximately CNY 3.80 billion compared to the end of the previous year[23]. - The basic earnings per share decreased by 15.33% to CNY 1.16[23]. - The weighted average return on equity decreased by 9.78 percentage points to 16.52%[23]. - The company's total revenue for the reporting period was CNY 1,743,894,964.42, representing a year-over-year decrease of 3.12%[58]. Market and Brand Strategy - The company operates under three brands: "Marubi," "Chunji," and "Lianhuo," focusing on differentiated brand positioning to meet diverse consumer needs[32]. - The "Marubi" brand focuses on anti-aging products using biotechnology, targeting the mid-to-high-end market[32]. - The company aims to leverage global leading technology to develop high-quality products and enhance its international competitiveness[32]. - The company is actively pursuing market expansion strategies, although specific details are not provided in the current report[21]. - The company has invested in emerging brands and established two industry funds, laying the foundation for a multi-brand strategy[51]. Research and Development - The company has a commitment to research and development of new products and technologies, although specific projects are not detailed in the current report[21]. - R&D expenses amounted to 50.15 million yuan, a year-on-year increase of 11.78%, with a total of 269 patents applied for, including 183 invention patents[42]. - The company maintained a dual-digit growth rate in R&D investment, with five research centers advancing simultaneously[42]. - Research and development expenses amounted to CNY 50,154,239.72, accounting for 2.87% of total revenue[67]. - The company has 88 R&D personnel, representing 9.26% of the total workforce[67]. Sales Performance - Online sales revenue reached 950 million yuan, a year-on-year increase of 17.59%, while offline sales revenue was 794 million yuan, a year-on-year decrease of 19.98%[40]. - The company achieved operating revenue of 1.745 billion yuan, a year-on-year decrease of 3.10%, with the main brand, Marubi, accounting for 95.06% of the revenue, remaining stable year-on-year[38]. - The company’s online revenue proportion exceeded offline for the first time, reaching 54.49%[41]. - The company’s sales expenses were 564 million yuan, a year-on-year increase of 4.38%[38]. - The company’s management expenses were 78.61 million yuan, a year-on-year decrease of 13.27%[40]. Compliance and Governance - The company has received a standard unqualified audit report from Huaxing Accounting Firm, ensuring the accuracy and completeness of the financial report[5]. - There are no non-operating fund occupations by controlling shareholders or related parties, ensuring financial integrity[8]. - The company has not reported any violations of decision-making procedures regarding external guarantees, indicating compliance with regulations[8]. - The company has maintained a stable governance structure with all board members present at the board meeting[5]. - The company has committed to avoiding related party transactions with its controlling shareholders and their affiliates[154]. Risk Management - The company has outlined potential risks in its future development, which are detailed in the operational discussion section of the report[8]. - The company faces risks from increasing market competition, necessitating continuous product innovation and brand strengthening to maintain its competitive edge[110]. - The company acknowledges potential impacts from the COVID-19 pandemic on its sales and supply chain, emphasizing the need for adaptive strategies[114]. Investment and Capital Management - The company has engaged in wealth management products with varying annualized return rates, such as 3.40% and 3.00%, reflecting a diversified investment strategy[171]. - The company has consistently redeemed wealth management products at maturity, demonstrating a reliable investment strategy[172]. - The company plans to maintain its investment strategy in wealth management, with a focus on principal protection and stable returns[176]. - The company has utilized both raised funds and self-owned funds for its wealth management investments, indicating a balanced approach to capital allocation[176]. Corporate Social Responsibility - The company donated RMB 5 million to the Guangzhou Charity Association for pandemic relief and produced hand sanitizers for partners[188]. - The company has achieved ISO 14001:2015 environmental management system certification and has established a comprehensive environmental management system[185]. - The company emphasizes long-term strategies and aims to create economic and social value while ensuring sustainable development[184].